NIH Partnered in Rebuilding and Transforming NYU Research Facilities From Aftermath of Superstorm Sandy
In October 2012, Superstorm Sandy hit the U.S. East Coast, causing devastation across the New York metropolitan area (Figure 1). Extensive water damage and power outages occurred throughout NYU Langone Health’s Manhattan main campus, affecting multiple research and clinical facilities and necessitating emergency patient evacuations.
T35/F30 Trainee, Kieran Koch-Laskowski, Ph.D., Advances Obesity Research
Dr. Kieran Koch-Laskowski, currently enrolled in the Combined D.V.M.–Ph.D. Program at Cornell University’s College of Veterinary Medicine, has had aspirations of pursuing veterinary school since childhood. Her innate love of animals and desire to help them steered her toward an undergraduate program at the University of Pennsylvania to earn a B.A. in the biological basis of behavior (neuroscience).
Supercomputing Technologies Funded by ORIP Helped Spur Approval of COVID-19 Vaccines and Save Lives*
Supercomputing has been gaining attention for its applications across biomedical research. A type of high-performance computing...
NIH ARRA Investment Funds State-of-the-Art Core Facility to Support the Future of RNA Medicine at Beth Israel Deaconess Medical Center
Dr. Frank Slack, Director of the Harvard Medical School Initiative for RNA Medicine (HIRM), envisions a promising future for RNA-based therapeutics...
ORIP Support for Small Businesses Leads to New Commercial Technology Outcomes That Benefit Community Resources and Advance Research Discoveries
ORIP participates in two federal grant programs that provide funding to small businesses: the Small Business Innovation Research (SBIR) program and the Small Business Technology Transfer (STTR) program. The primary goal of ORIP’s small business programs is to attract innovative SBIR/STTR projects that could benefit research resources and communities associated with ORIP’s mission.
ARRA Program Helps Enable Revolutionary Discoveries in Gene Therapy
Located within the heart of the Children’s Hospital of Philadelphia (CHOP) Research Institute, the Clinical Vector Core (CVC) fills a unique role within the biomedical research community. The CVC provides services to academic, industry, and government groups for the advancement of gene therapy research. An ORIP award (G20RR030997) administered through the 2009 American Recovery and Reinvestment Act (ARRA) grant program—whose goals were to stimulate the U.S.
Profile of a Promising HIV/AIDS Scholar: Riti Sharan, Ph.D.
As an immunologist studying HIV, latent tuberculosis infection (LTBI), and possible treatments, Dr. Riti Sharan (Figure 1) has been intrigued by the human body since high school, particularly the complex and varied mechanisms by which it defends itself against pathogens.
Mouse Research Yields New Insights on Mendelian Disease Genetics
Gregor Mendel’s work in the 19th century laid the foundation for our current understanding of heritability—the ways in which phenotypes (i.e., an individual’s observable traits) are...
Cell Ablation System in Zebrafish Yields Insights on Cellular Regeneration
The zebrafish (Danio rerio) has been used by researchers as a model organism for human disease for decades. In recent years, however, the zebrafish has gained considerable...